NCT04380857View on ClinicalTrials.gov

Assessing Dextenza Insert After SMILE Procedure

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

June 21, 2021

Study Completion Date

June 21, 2021

Conditions
Post Procedural Infection
Interventions
DRUG

Dexamethasone ophthalmic insert 0.4 mg

intracanalicular dexamethasone insert

DRUG

Topical Prednisolone Acetate Ophthalmic Drops

"Topical Prednisolone acetate ophthalmic drops per standard of care:~Every two hours on day of procedure, then four times a day for the first week, then two times a day for the second week, then discontinue"

Trial Locations (1)

44141

Cleveland Eye Clinic, Brecksville

All Listed Sponsors
lead

William Wiley, MD

OTHER

NCT04380857 - Assessing Dextenza Insert After SMILE Procedure | Biotech Hunter | Biotech Hunter